This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma
Scientific Reports Open Access 13 February 2024
-
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
Nature Communications Open Access 22 December 2022
-
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment
GeroScience Open Access 12 December 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fowler JA, Lwin ST, Drake MT, Edwards JR, Kyle RA, Mundy GR et al. Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease. Blood 2011; 118: 5872–5882.
Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance (MGUS) among African-American and Caucasian women. Blood 2010; 116: 1056–1059.
Wallin A, Larsson SC . Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 2011; 47: 1606–1615.
Carson KR, Bates ML, Tomasson MH . The skinny on obesity and plasma cell myeloma: a review of the literature. Bone Marrow Transplant 2014; 49: 1009–1015.
Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K et al. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. Br J Haematol 2014; 166: 667–676.
Hofmann JN, Moore SC, Lim U, Park Y, Baris D, Hollenbeck AR et al. Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP diet and health study. Am J Epidemiol 2013; 177: 776–786.
Murphy F, Kroll ME, Pirie K, Reeves G, Green J, Beral V . Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study. Br J Cancer 2013; 108: 2390–2398.
Radl J, Croese JW, Zurcher C, Van den Enden-Vieveen MH, de Leeuw AM . Animal model of human disease. Multiple myeloma. Am J Pathol 1988; 132: 593–597.
Fowler JA, Mundy GR, Lwin ST, Edwards CM . Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1. Cancer Res 2012; 72: 2183–2189.
Kyle RA, Rajkumar SV . Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Hematol Oncol Clin North Am 2007; 21: 1093–1113.
Ng AC, Khosla S, Charatcharoenwitthaya N, Kumar SK, Achenbach SJ, Holets MF et al. Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1alpha levels in patients with MGUS. Blood 2011; 118: 6529–6534.
Coleman DL, Hummel KP . The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973; 9: 287–293.
Ribeiro AM, Andrade S, Pinho F, Monteiro JD, Costa M, Lopes C et al. Prostate cancer cell proliferation and angiogenesis in different obese mice models. Int J Exp Pathol 2010; 91: 374–386.
Georgii-Hemming P, Wiklund HJ, Ljunggren O, Nilsson K . Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines. Blood 1996; 88: 2250–2258.
Beason TS, Chang SH, Sanfilippo KM, Luo S, Colditz GA, Vij R et al. Influence of body mass in dex on survival in veterans with multiple myeloma. Oncologist 2013; 18: 1074–1079.
Acknowledgements
This work was supported by the National Cancer Institute through R01-CA137116, an American Society of Bone and Mineral Research Career Establishment Award and a Marie Curie Career Integration Grant within the 7th European Community Framework Programme.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Lwin, S., Olechnowicz, S., Fowler, J. et al. Diet-induced obesity promotes a myeloma-like condition in vivo. Leukemia 29, 507–510 (2015). https://doi.org/10.1038/leu.2014.295
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2014.295
This article is cited by
-
Diet-induced obesity reduces bone marrow T and B cells and promotes tumor progression in a transplantable Vk*MYC model of multiple myeloma
Scientific Reports (2024)
-
Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment
GeroScience (2023)
-
Calorie restriction has no effect on bone marrow tumour burden in a Vk*MYC transplant model of multiple myeloma
Scientific Reports (2022)
-
Modulating glycosphingolipid metabolism and autophagy improves outcomes in pre-clinical models of myeloma bone disease
Nature Communications (2022)
-
High-fat diet intensifies MLL-AF9-induced acute myeloid leukemia through activation of the FLT3 signaling in mouse primitive hematopoietic cells
Scientific Reports (2020)